MIMS Research Foundation is developing a novel drug to treat coronavirus Usha Sharma Mar 31, 2021 The company have repurposed its sepsis research for COVID management
Researchers at IISER Bhopal, Nebraska University identify drug that can be repurposed to treat… EP News Bureau Mar 22, 2021 Rapamycin used to prevent organ rejection after transplants and in cancer treatment was found to have anti-ageing effect and…
Ruxolitinib (Jakafi) does not prevent complications due to COVID-19 associated cytokine storm: Study EP News Bureau Dec 14, 2020 There was no reduction in the proportion of patients receiving ruxolitinib plus SoC who experienced severe complications including…
Study recommends steroid treatment should be given only to sickest COVID-19 patients Press Trust of India Nov 16, 2020 While dexamethasone and other steroids are prescribed to treat cytokine storms, these drugs can backfire in patients whose immune…
Zydus Cadila files IND application for ZYIL1, NLRP3 inflammasome inhibitor EP News Bureau Nov 3, 2020 It can selectively modulate the inflammatory responses caused by the ‘Cytokine Storm’ in ARDS, COVID19 and other inflammatory…
Researchers find corticosteroids combo is most effective for COVID-19 cytokine storm treatment EP News Bureau Oct 21, 2020 Additionally, there was an improvement if corticosteroids were used alone, or in combination with tocilizumab or anakinra when…
Scientists find new drug that may be able to prevent or mitigate severe COVID-19 infection Press Trust of India Sep 21, 2020 Repurposing the 4-PBA anti-stress drug could modulate such cellular stress and curb mortality caused by respiratory failure…
Anti-inflammatory and cancer drugs tested in UK as possible COVID-19 therapy Reuters Jun 11, 2020 Izana Bioscience's Namilumab, a monoclonal antibody already in late-stage tests to treat rheumatoid arthritis and an inflammatory…
Biocon Biologics gets DCGI approval for emergency use of CytoSorb to treat critical COVID-19… EP News Bureau May 27, 2020 US FDA recently approved CytoSorb for emergency use in COVID-19 patients